These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 4112423)
1. Fine structural aspects of demyelination in vitro. The effects of Guillain-Barré serum. Hirano A; Cook SD; Whitaker JN; Dowling PC; Murray MR J Neuropathol Exp Neurol; 1971 Apr; 30(2):249-65. PubMed ID: 4112423 [No Abstract] [Full Text] [Related]
2. The action of Guillain-Barrĕ syndrome serum on myelin. A tissue culture and electron microscopic analysis. Dubois-Dalcq M; Buyse M; Buyse G; Gorce F J Neurol Sci; 1971 May; 13(1):67-83. PubMed ID: 5105788 [No Abstract] [Full Text] [Related]
13. A case of pandysautonomia with associated sensory ganglionopathy. Kurokawa K; Noda K; Mimori Y; Watanabe C; Katayama S; Nakamura S; Sannomiya K; Yamamoto S; Tahara E J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):278-9. PubMed ID: 9703192 [No Abstract] [Full Text] [Related]
14. Patterns of myelin degeneration following the rapid death of cells in cultures of peripheral nervous tissue. Masurovsky EB; Bunge RP J Neuropathol Exp Neurol; 1971 Jul; 30(3):311-24. PubMed ID: 5105892 [No Abstract] [Full Text] [Related]
15. Landry-Guillain-Barré syndrome. A primary demyelinating disease. Wiśniewski H; Terry RD; Whitaker JN; Cook SD; Dowling PC Arch Neurol; 1969 Sep; 21(3):269-76. PubMed ID: 5802459 [No Abstract] [Full Text] [Related]
16. The occurrence of IgM and complement factors along myelin sheaths of peripheral nerves. An immunohistochemical study of the Guillain-Barré syndrome. Preliminary communication. Luijten JA; Baart de la Faille-Kuyp J Neurol Sci; 1972 Feb; 15(2):219-24. PubMed ID: 4334504 [No Abstract] [Full Text] [Related]